These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 5483974)

  • 101. The influence of some anticoagulants and fibrinolytic substances on mice fibroblasts (strain L) in tissue culture.
    PETERS K; MATIS P
    Thromb Diath Haemorrh; 1961 Sep; 6():381-5. PubMed ID: 14485742
    [No Abstract]   [Full Text] [Related]  

  • 102. [Studies on the fibrinolytic activity of red blood cells. I. Fibrinolytic activities of bone marrow red blood cells and venous red blood cells].
    Sakuragawa N
    Nihon Ketsueki Gakkai Zasshi; 1966 Nov; 29(6):910-27. PubMed ID: 6009656
    [No Abstract]   [Full Text] [Related]  

  • 103. Urokinase levels in urine after nicotinic acid injection.
    Holemans R; McConnell D; Johnston JG
    Thromb Diath Haemorrh; 1966 Jan; 15(1):192-204. PubMed ID: 4224093
    [No Abstract]   [Full Text] [Related]  

  • 104. [Immobilized proteases and their activators as immunocorrective agents].
    Khmelevskaia IG; Ragulina VA; Konoplia AI; Chalyĭ GA
    Antibiot Khimioter; 1997; 42(3):11-4. PubMed ID: 9265460
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Plasmatic and thrombocytic anti-plasmins and anti-activators. II.
    den Ottolander GJ; Leijnse B; Cremer-Elfrink HM
    Thromb Diath Haemorrh; 1969 Feb; 21(1):26-34. PubMed ID: 4237623
    [No Abstract]   [Full Text] [Related]  

  • 106. Proceedings: Endogenously increased fibrinolytic activity induced by liver-bypass in pigs and its in vitro synergism with synthetic fibrinolytic compounds.
    Ostendorf R; von Kaulla KN
    Thromb Diath Haemorrh; 1975 Sep; 34(1):319-20. PubMed ID: 1188726
    [No Abstract]   [Full Text] [Related]  

  • 107. Plasma fibrinolytic and leukocyte proteolytic activities: differentiaton by activating and inhibiting factors.
    Gibiński K; Zahorska-Markiewicz B; Markiewicz A
    Acta Med Pol; 1970; 11(2):97-101. PubMed ID: 5310710
    [No Abstract]   [Full Text] [Related]  

  • 108. [Pharmacological aspects of fibrinolysis].
    Prino G; Mantovani M
    Boll Chim Farm; 1969 Nov; 108(11):655-75 contd. PubMed ID: 5378688
    [No Abstract]   [Full Text] [Related]  

  • 109. Experimental studies of essential hemospermia with special reference to the fibrinolytic activity.
    Kozaka S
    Hinyokika Kiyo; 1971 Apr; 17(4):253-77. PubMed ID: 5165320
    [No Abstract]   [Full Text] [Related]  

  • 110. [Tissue culture as a test system for the study of fibrinolysis activators].
    Astedt B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):399-403. PubMed ID: 63427
    [No Abstract]   [Full Text] [Related]  

  • 111. Tissue fibrinolytic activity studied by a histochemical method.
    Kwaan HC
    Fed Proc; 1966; 25(1):52-6. PubMed ID: 5006572
    [No Abstract]   [Full Text] [Related]  

  • 112. Use of anticoagulant and fibrinolytic agents.
    MOSER KM
    Dis Mon; 1960 Mar; 1960():1-44. PubMed ID: 13848677
    [No Abstract]   [Full Text] [Related]  

  • 113. How drugs act-17. Drugs and the blood.
    Smith SE
    Nurs Times; 1975 Oct; 71(42):1665-6. PubMed ID: 1196926
    [No Abstract]   [Full Text] [Related]  

  • 114. [Perspectives for the utilization of pyrogens as a factor activating fibrinolytic system of the blood].
    KOKOT F; GONCIARZ Z
    Pol Tyg Lek; 1961 May; 16():685-7. PubMed ID: 13757682
    [No Abstract]   [Full Text] [Related]  

  • 115. [Tricholysine-induced histological changes in experimental thrombosis].
    Gavrilov OK; Glasko EN; Murashova NS; Siretenko AV; Subbotina LA
    Gematol Transfuziol; 1983 Aug; 28(8):50-2. PubMed ID: 6354831
    [No Abstract]   [Full Text] [Related]  

  • 116. Venous fibrinolytic activity and histologic features with distention.
    Malone JM; Gervin AS; Kischer CW; Keown K; Moore WS
    Surg Forum; 1978; 29():479-80. PubMed ID: 401230
    [No Abstract]   [Full Text] [Related]  

  • 117. Studies on the haemostatic system in peripheral arterial disease. I. Factor VIII, fibrinolytic activity, and changes induced by venous occlusion and nicotinic acid administration.
    Ponari O; Manotti C; Poti R; Vaona G; Dettori AG
    Thromb Res; 1981 Jun 1-25; 22(5-6):565-72. PubMed ID: 6795751
    [No Abstract]   [Full Text] [Related]  

  • 118. Development of thrombolytic activity.
    VERSTRAETE M
    Thromb Diath Haemorrh; 1961; 6(Suppl 1)():238-9. PubMed ID: 13996900
    [No Abstract]   [Full Text] [Related]  

  • 119. [Problem of fibrinolysis in experimental coagulation- and mixed thrombi].
    SANDRITTER W; HUPPERT M; SCHLUTER G
    Klin Wochenschr; 1958 Jul; 36(14):651-5. PubMed ID: 13576736
    [No Abstract]   [Full Text] [Related]  

  • 120. The role of the arterial wall in the mechanism of thrombosis and lysis. Experimental study.
    Courbier R; Baille Y; Goudard A; Boutros H; Henry E
    J Cardiovasc Surg (Torino); 1969; 10(5):355-61. PubMed ID: 5365325
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.